These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8519649)

  • 1. Differences in resistance to 5-fluorouracil as a function of cell cycle delay and not apoptosis.
    Pickard M; Dive C; Kinsella AR
    Br J Cancer; 1995 Dec; 72(6):1389-96. PubMed ID: 8519649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of both salvage and DNA damage response pathways on resistance to chemotherapeutic antimetabolites.
    Pickard M; Kinsella A
    Biochem Pharmacol; 1996 Aug; 52(3):425-31. PubMed ID: 8687496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines.
    Eisold S; Linnebacher M; Ryschich E; Antolovic D; Hinz U; Klar E; Schmidt J
    World J Gastroenterol; 2004 Dec; 10(24):3583-9. PubMed ID: 15534911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells.
    Stravopodis DJ; Karkoulis PK; Konstantakou EG; Melachroinou S; Thanasopoulou A; Aravantinos G; Margaritis LH; Anastasiadou E; Voutsinas GE
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):359-74. PubMed ID: 20425122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance.
    de la Cruz-Morcillo MA; Valero ML; Callejas-Valera JL; Arias-González L; Melgar-Rojas P; Galán-Moya EM; García-Gil E; García-Cano J; Sánchez-Prieto R
    Oncogene; 2012 Mar; 31(9):1073-85. PubMed ID: 21841826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective protection of non-cancer cells by hypothermia.
    Matijasevic Z
    Anticancer Res; 2002; 22(6A):3267-72. PubMed ID: 12530074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
    McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
    Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
    Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation.
    Xavier CP; Lima CF; Rohde M; Pereira-Wilson C
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1449-57. PubMed ID: 21479885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cisplatin, 5-fluorouracil, and radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line.
    Lee BJ; Chon KM; Kim YS; An WG; Roh HJ; Goh EK; Wang SG
    Chemotherapy; 2005 May; 51(2-3):103-10. PubMed ID: 15886465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
    Adamsen BL; Kravik KL; De Angelis PM
    Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.
    Chen XX; Lai MD; Zhang YL; Huang Q
    World J Gastroenterol; 2002 Oct; 8(5):841-6. PubMed ID: 12378627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2.
    Fedier A; Ruefenacht UB; Schwarz VA; Haller U; Fink D
    Br J Cancer; 2002 Oct; 87(9):1027-33. PubMed ID: 12434296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.